open access publication

Article, 2024

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Leukemia, ISSN 1476-5551, 0887-6924, Pages 1-4, 10.1038/s41375-024-02329-0

Contributors

Moorman, Anthony Vincent 0000-0002-9781-6107 (Corresponding author) [1] Enshaei, Amir 0000-0002-7464-0743 [1] Murdy, Daniel [1] Joy, Melvin 0000-0001-9323-994X [1] Boer, Judith M 0000-0003-4848-7789 [2] Den Boer, Monique L 0000-0002-5795-2921 [2] Pieters, Rob [2] De Haas, Valerie [2] Horstmann, Martin A 0000-0001-8559-8862 [3] Escherich, Gabriele [3] Johansson, B Jonas [4] Marquart, Hanne Vibeke Hansen 0000-0001-9740-6522 [5] [6] Schmiegelow, Kjeld 0000-0002-0829-4993 [5] [6] Hancock, Jeremy P [7] Moppett, John P 0000-0003-1844-3531 [8] Heyman, Mats Marshall [9] [10]

Affiliations

  1. [1] Newcastle University
    2. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  2. [2] Princess Máxima Center
    3. [NORA names: Netherlands; Europe, EU; OECD];
  3. [3] University Medical Center Hamburg-Eppendorf
    4. [NORA names: Germany; Europe, EU; OECD];
  4. [4] Lund University
    5. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  5. [5] Rigshospitalet
    6. [NORA names: Capital Region of Denmark; Hospital; Denmark; Europe, EU; Nordic; OECD];

Keywords

B cells, B-cell precursor acute lymphoblastic leukemia, MRD, MRD levels, acute lymphoblastic leukemia, genetics, induction, integration, integration of genetics, leukemia, levels, low-risk patients, lymphoblastic leukemia, patients, risk patients

Funders

  • Blood Cancer UK
  • Cancer Research UK

Data Provider: Digital Science

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+